For patients receiving adjuvant trastuzumab for HER2+ positive breast cancer, if a patient misses a dose, do you make up that dose or stop at 1 year mark without making the dose up?   

What factors influence your decision?



Answer from: Medical Oncologist at Academic Institution
Comments
Medical Oncologist
While i agree that relative dose intensity especia...
Medical Oncologist at Washington University School of Medicine
I agree with Dr Gluck.
Medical Oncologist at Mayo Clinic Rochester
Agree with Dr Gluck -- it is hard to get excited a...
Sign in or Register to read more